Galvanize Therapeutics, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Galvanize Therapeutics, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Galvanize Therapeutics, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 7, 2026 to May 7, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OAB appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 3200 Bridge Pkwy., Redwood City, CA, 94065, US. Recorded on K253826, decision dated May 7, 2026.
Device categories in this collection
Low Energy Direct Current Thermal Ablation System.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Aliya EX System; Aliya EX Generator; Aliya Needle; Aliya Electrode; INUMI Flex Needle
K253826 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.